Additional Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    CIC Mauricie
    Trois-Rivières QC. G8T7A1
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Central Florida Pulmonary Group
    Orlando FL. 32803
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    SEC Clinical Research
    Pensacola FL. 32503
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Summit Health
    Bend OR. 97701
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    NYU Langone Health
    New York NY. 10017
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Accellacare
    Wilmington NC. 28401
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Paradigm Clinical Research - Redding
    Redding CA. 96001
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Clinical Site Partners
    Winter Park FL. 32789
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Renstar Medical Research
    Ocala FL. 34470
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Lowcountry Lung and Critical Care
    Charleston SC. 29406
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Newport Native MD, Inc.
    Newport Beach CA. 92663
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis

    Clinical Site Partners, LCC
    Leesburg FL. 34748
    View Details

  • The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Mayo Clinic
    Phoenix AZ. 85054
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    MUSC Pulmonary Research
    Charleston SC. 29425
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Montefiore Medical Center
    Bronx NY. 10467
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Mayo Clinic
    Jacksonville FL. 32224
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Newport Native MD, Inc.
    Newport Beach CA. 92663
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details